N-Butyl-N-(4-hydroxybutyl)nitrosamine
CAS: 3817-11-6
Ref. 3D-FB177815
| 1g | Descontinuado | ||
| 2g | Descontinuado | ||
| 5g | Descontinuado | ||
| 10g | Descontinuado | ||
| 25g | Descontinuado |
Informação sobre produto
Nome:
N-Butyl-N-(4-hydroxybutyl)nitrosamine
Sinónimos:
- 1-Butanol, 4-(butylnitrosamino)-
- 1-Butanol, 4-(butylnitrosoamino)-
- 4-(Butylnitrosoamino)-1-butanol
- 4-Hydroxybutylbutylnitrosamine
- 4-[Butyl(Nitroso)Amino]Butan-1-Ol
- Butyl(4-hydroxybutyl)nitrosamine
- N-Butyl-N-(1-hydroxybutyl)nitrosamine
- N-Nitrosobutyl-4-hydroxybutylamine
- N-Nitrosobutylbutan-4-olamine
- N-n-Butyl-N-butan-4-ol-nitrosamine
- Ver mais sinónimos
Descrição:
N-Butyl-N-(4-hydroxybutyl)nitrosamine (BBN) is a genotoxic carcinogen that causes urothelial carcinoma in laboratory animals. It is also a potential biomarker for bladder cancer in humans, based on the detection of BBN in maternal blood and urine. The pharmacological mechanism of BBN is not yet clear, but it may be due to its sodium salt or the presence of other genotoxic chemicals. A rat model has been developed for BBN toxicity studies. This drug inhibits protein synthesis by inhibiting RNA polymerase II and III, which are responsible for gene transcription and translation respectively.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
174.24 g/mol
Fórmula:
C8H18N2O2
Pureza:
90%Min
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
